The agreement with Pfizer is part of the Trump administration's strategy to implement the 'most favored nation' model, ensuring that the U.S. pays competitive prices for medications. Pfizer will reduce prices on a large scale and will launch the 'TrumpRx' platform for direct sales to patients. Additionally, the company will invest 70 billion dollars in research and production in the U.S.
Sources
Latest News
23:00
NASA has published images of the crater formed on the Moon after the Falcon 9 rocket stage crashed on August 5.
22:53
ECB: Europe cannot afford to miss the opportunities offered by artificial intelligence
22:49
Energy consumption is on the rise. When is the peak consumption expected this year?
22:45
The assessment of the buildings affected by the explosion in Rahova has begun. The operation will conclude on September 9.
22:35
Bogdan Ivan responds to Ilie Bolojan, asking him to confirm that large energy consumers will not be affected by power cuts.
See more news